Compare Cassava Sciences Inc (FLNA) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs PPG Industries, Inc. — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while PPG Industries, Inc. trades at $105.43 (market cap $23.44B). The key difference: PPG Industries, Inc. is far larger — about 594.9× Cassava Sciences Inc's market cap, and PPG Industries, Inc. pays a 2.81% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and PPG Industries, Inc. for 68 Days on average.
| FLNA | PPG | |
|---|---|---|
Market Cap | $39.40M | $23.44B |
Volume | 759,018 | 2,064,777 |
Sector | Health | Basic Materials |
52-Week High | $4.64 | $131.56 |
52-Week Low | $0.68 | $94.34 |
Typical Hold Time | 37 Days | 68 Days |
Enterprise Value | -$43.28M | $29.31B |
Dividend Yield | — | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8157, down 6.77% today, with a bearish technical signal from moving averages. The company shows improving quarterly EPS trends, beating expectations in recent quarters, though it remains unprofitable with negative ROE and ROA. Recent FDA clearance for its epilepsy drug trial provides a positive catalyst. Analyst sentiment is bullish with 67% buy ratings.
The outlook hinges on clinical progress; upside exists if Phase 2a trials succeed, but high cash burn and lack of revenue pose significant risks. Investors should weigh the strong analyst support against the company's financial challenges and binary clinical outcomes.
PPG Industries trades at $105.08, down 1.37% on the day, with technical indicators showing bearish momentum. The stock demonstrates solid fundamentals with a P/E of 15.08, net income margin of 9.57%, and strong cash flow generation of $1.94B from operations in 2025. Recent earnings show mixed results with Q1 2026 beating expectations but Q2 2026 missing estimates, while the company maintains its Dividend King status with consistent payouts.
The outlook remains cautiously optimistic with a $130 consensus price target representing 24% upside potential. Key risks include margin pressures in the Automotive Refinish segment and European demand weakness. Analyst consensus leans bullish with 55% buy ratings, though technical weakness suggests potential near-term consolidation before fundamental strength drives recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
